• LAST PRICE
    34.5800
  • TODAY'S CHANGE (%)
    Trending Up1.4200 (4.2823%)
  • Bid / Lots
    34.5200/ 2
  • Ask / Lots
    34.6000/ 2
  • Open / Previous Close
    32.9400 / 33.1600
  • Day Range
    Low 32.9000
    High 35.4000
  • 52 Week Range
    Low 15.7350
    High 38.6800
  • Volume
    221,182
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 33.16
TimeVolumeRLMD
09:32 ET565433.55
09:36 ET20033.44
09:38 ET237033.025
09:39 ET96133.165
09:41 ET158433.25
09:43 ET286033.5
09:45 ET40033.74
09:48 ET10033.75
09:52 ET314933.6
09:54 ET34533.7515
09:56 ET492734.08
09:57 ET105034.24
09:59 ET30034.16
10:03 ET218034.03
10:06 ET27534.141
10:08 ET1380034.21
10:10 ET120234.22
10:12 ET110034.47
10:14 ET10034.5153
10:15 ET102634.5933
10:17 ET119234.9
10:19 ET865734.635
10:21 ET341934.775
10:24 ET110034.5566
10:26 ET60034.23
10:28 ET60034.15
10:30 ET90034.09
10:32 ET241434.09
10:33 ET50034.34
10:35 ET166034.62
10:37 ET137034.37
10:39 ET132834.46
10:42 ET872334.56
10:44 ET310534.6271
10:46 ET68734.69
10:48 ET94334.7707
10:50 ET120034.55
10:51 ET58234.51
10:53 ET299034.49
10:55 ET10034.5272
10:57 ET10034.515
11:02 ET90034.68
11:04 ET90134.69
11:06 ET10034.69
11:08 ET2223934.78
11:09 ET131034.91
11:11 ET20035.12
11:13 ET294635.1
11:15 ET85635.165
11:18 ET60035.18
11:20 ET262035.26
11:22 ET41635.3569
11:24 ET273935.2968
11:26 ET170035.2
11:27 ET10035.255
11:29 ET20035.26
11:31 ET181535.03
11:33 ET20035.03
11:36 ET161035
11:38 ET50235.056
11:40 ET221435.1062
11:42 ET140034.93
11:44 ET94334.7087
11:45 ET203534.74
11:49 ET637134.62
11:51 ET250234.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRLMD
Relmada Therapeutics Inc
955.3M
-5.0x
---
United StatesFMTX
Forma Therapeutics Holdings Inc
952.7M
-5.0x
---
United StatesCRNX
Crinetics Pharmaceuticals Inc
973.5M
-6.3x
---
United StatesERAS
Erasca Inc
927.3M
-6.3x
---
United StatesCOGT
Cogent Biosciences Inc
946.3M
-5.8x
---
United StatesRNA
Avidity Biosciences Inc
977.4M
-5.0x
---
As of 2022-10-05

Company Information

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), which is an N-methyl-D-aspartate (NMDA) receptor antagonist. The Company’s lead product candidate, esmethadone, is a new chemical entity (NCE) developed as a rapidly acting, oral agent for the treatment of depression, central nervous system (CNS) diseases and other potential indications. The Company’s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission and is in development for both the adjunctive or monotherapy treatment of major depressive disorder (MDD).

Contact Information

Headquarters
2222 Ponce De Leon Blvd. 3Rd FloorCORAL GABLES, FL, United States 33134
Phone
646-876-3459
Fax
---

Executives

Independent Chairman of the Board
Charles Casamento
Chief Executive Officer, Director
Sergio Traversa
Chief Financial Officer
Maged Shenouda
Chief Accounting, Compliance Officer
Charles Ence
Acting Chief Scientific Officer
Paolo Manfredi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$955.3M
Revenue (TTM)
$0.00
Shares Outstanding
30.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.58
EPS
$-6.97
Book Value
$7.51
P/E Ratio
-5.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.